Executive dysfunction in Parkinson's disease: A review

Journal of Neuropsychology

Volumn 7, Issue 2, 2013, Pages 193-224

  Dirnberger, Georg ^a   Jahanshahi, Marjan ^b  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

cognition; dopamine overdose; executive function; Parkinson's disease

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

BASAL GANGLION; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DISEASE COURSE; DOPAMINE OVERDOSE; DRUG EFFECT; EXECUTIVE FUNCTION; HUMAN; PARKINSON DISEASE; PATHOLOGY; PSYCHOLOGICAL ASPECT; SYMPTOM ASSESSMENT;

COGNITION; DOPAMINE OVERDOSE; EXECUTIVE FUNCTION; PARKINSON'S DISEASE;

BASAL GANGLIA; COGNITION DISORDERS; DISEASE PROGRESSION; DOPAMINE AGONISTS; EXECUTIVE FUNCTION; HUMANS; PARKINSON DISEASE; SYMPTOM ASSESSMENT;

EID: 84883707873     PISSN: 17486645     EISSN: 17486653     Source Type: Journal    
DOI: 10.1111/jnp.12028     Document Type: Conference Paper

References (194)

1. Aarsland, D., Andersen, K., Larsen, J., Lolk, A., &, Kragh-Sørensen, P., (2003). Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Archives of Neurology, 60, 387-392.
2. Aarsland, D., Brønnick, K., Alves, G., Tysnes, O., Pedersen, K., Ehrt, U., &, Larsen, J., (2009). The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 80, 928-930.
3. Aarsland, D., Larsen, J., Karlsen, K., Lim, N., &, Tandberg, E., (1999). Mental symptoms in Parkinson's disease are important contributors to caregiver distress. International Journal of Geriatric Psychiatry, 14, 866-874.
4. Aarsland, D., Tandberg, E., Larsen, J., &, Cummings, J., (1996). Frequency of dementia in Parkinson disease. Archives of Neurology, 53, 538-542.
5. Abe, N., Fujii, T., Hirayama, K., Takeda, A., Hosokai, Y., Ishioka, T.,., Mori, E., (2009). Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour. Brain, 132, 1386-1395.
6. Allcock, L. M., Rowan, E., Steen, I., Wesnes, K., Kenny, R., &, Burn, D., (2009). Impaired attention predicts falling in Parkinson's disease. Parkinsonism and Related Disorders, 15, 110-115.
7. Altgassen, M., Zollig, J., Kopp, U., Mackinlay, R., &, Kliegel, M., (2007). Patients with Parkinson's disease can successfully remember to execute delayed intentions. Journal of the International Neuropsychological Society, 13, 888-892.
8. Amboni, M., Barone, P., Picillo, M., Cozzolino, A., Longo, K., Erro, R., &, Iavarone, A., (2010). A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. Movement Disorders, 25, 800-802.
9. Amboni, M., Cozzolino, A., Longo, K., Picillo, M., &, Barone, P., (2008). Freezing of gait and executive functions in patients with Parkinson's disease. Movement Disorders, 23, 395-400.
10. Anderson, P., (2002). Assessment and development of executive function during childhood. Child Neuropsychology, 8, 71-82.
11. Anderson, V., Northam, E., Hendy, J., &, Wrenall, J., (2001). Developmental neuropsychology: A clinical approach. New York, NY: Psychology Press.
12. Baddeley, A. D., &, Hitch, G. J., (1974). Working memory. In, G. H. Bower, (Ed.), The psychology of learning and motivation: Advances in research and theory (pp. 47-89). New York, NY: Academic.
13. Barnes, J., &, Boubert, L., (2008). Executive functions are impaired in patients with Parkinson's disease with visual hallucinations. Journal of Neurology, Neurosurgery and Psychiatry, 79, 190-192.
14. Bassetti, C., (2011). Nonmotor disturbances in Parkinson's disease. Neurodegenerative Diseases, 8, 95-108.
15. Benecke, R., Rothwell, J., Dick, J., Day, B., &, Marsden, C., (1986). Parkinson's disease. Brain, 109, 739-757.
16. Benoit-Leon, J., Louis, E., Posada, I., Sánchez-Ferro, A., Trincado, R., Villarejo, A.,., Bermejo-Pareja, F., (2011). Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES). Journal of the Neurological Sciences, 310, 176-182.
17. Benton, A., (1968). Differential behavioral effects in frontal lobe disease. Neuropsychologia, 6, 53-60.
18. Bloem, B. R., Valkenburg, V., Slabbekoorn, M., &, van Dijk, J., (2001). The multiple tasks test. Strategies in Parkinson's disease. Experimental Brain Research, 137, 478-486.
19. Boeve, B., (2007). Parkinson-related dementias. Neurologic Clinics, 25, 761-781.
20. Bouquet, C., Bonnaud, V., &, Gil, R., (2003). Investigation of supervisory attentional system functions in patients with Parkinson's disease using the Hayling task. Journal of Clinical and Experimental Neuropsychology, 25, 751-760.
21. Brand, M., Labudda, K., Kalbe, E., Hilker, R., Emmans, D., Fuchs, G.,., Markowitsch, H., (2004). Decision-making impairments in patients with Parkinson's disease. Behavioral Neurology, 15, 77-85.
22. Brand, M., Labudda, K., &, Markowitsch, H., (2006). Neuropsychological correlates of decision-making in ambiguous and risky situations. Neural Networks, 19, 1266-1276.
23. Bronnick, K., Ehrt, U., Emre, M., De Deyn, P., Wesnes, K., Tekin, S., &, Aarsland, D., (2006). Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 77, 1136-1142.
24. Brown, R. G., Jahanshahi, M., &, Marsden, C. D., (1993). Parkinson's, Huntington's and cerebellar disease. Journal of Neurology, Neurosurgery and Psychiatry, 56, 295-297.
25. Brown, R. G., &, Marsden, C. D., (1988a). An investigation into the phenomenon of 'set' in Parkinson's disease. Movement Disorders, 3, 152-161.
26. Brown, R. G., &, Marsden, C. D., (1988b). Internal versus external cues and the control of attention in Parkinson's disease. Brain, 111, 323-345.
27. Brown, R. G., &, Marsden, C. D., (1991). Parkinson's disease. Brain, 114, 215-231.
28. Brown, R. G., Soliveri, P., &, Jahanshahi, M., (1998). Executive processes in Parkinson's disease-Random number generation and response suppression. Neuropsychologia, 36, 1355-1362.
29. Brusa, L., Tiraboschi, P., Koch, G., Peppe, A., Pierantozzi, M., Ruggieri, S., &, Stanzione, P., (2005). Pergolide effect on cognitive functions in early mild Parkinson's disease. Journal of Neural Transmission, 112, 231-237.
30. Bugalho, P., &, Vale, J., (2011). Brief cognitive assessment in the early stages of Parkinson disease. Cognitive and Behavioral Neurology, 24, 169-173.
31. Burgess, P., (1997). Theory and methodology in executive function research. In, P. Rabbitt, (Ed.), Methodology of fontal and executive function (pp. 81-116). Hove, UK: Psychology Press.
32. Burgess, P., &, Alderman, N., (2004). Executive dysfunction. In, L. Goldstein, &, J. McNeil, (Eds.), Clinical neuropsychology: A practical guide to assessment and management for clinicians (Chapter 9). Chichester, UK: John Wiley.
33. Butterfield, L., Cimino, C., Oelke, L., Hauser, R., &, Sanchez-Ramos, J., (2010). The independent influence of apathy and depression on cognitive functioning in Parkinson's disease. Neuropsychology, 24, 721-730.
34. Cools, R., Altamirano, L., &, D'Esposito, M., (2006). Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia, 44, 1663-1673.
35. Cools, R., Barker, R., Sahakian, B., &, Robbins, T., (2001). Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex, 11, 1136-1143.
36. Cools, R., Barker, R., Sahakian, B., &, Robbins, T., (2003). L-dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia, 41, 1431-1441.
37. Cools, R., Rogers, R., Barker, R., &, Robbins, T., (2009). Top-down attentional control in Parkinson's disease: Salient considerations. Journal of Cognitive Neuroscience, 22, 848-859.
38. Cooper, J., Sagar, H., Doherty, S., Jordan, N., Tidswell, P., &, Sullivan, E., (1992). Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain, 115, 1701-1725.
39. Cooper, J., Sagar, H., Tidswell, P., &, Jordan, N., (1994). Slowed central processing in simple and go/no-go reaction time tasks in Parkinson's disease. Brain, 117, 517-529.
40. Costa, A., Peppe, A., Brusa, L., Caltagirone, C., Gatto, I., &, Carlesimo, G., (2008). Dopaminergic modulation of prospective memory in Parkinson's disease. Behavioral Neurology, 19, 45-48.
41. Czernecki, V., Pillon, B., Houeto, J., Pochon, J., Levy, R., &, Dubois, B., (2002). Motivation, reward, and Parkinson's disease: Influence of dopa therapy. Neuropsychologia, 40, 2257-2267.
42. Damholdt, M., Borghammer, P., Larsen, L., &, Ostergaard, K., (2011). Odor identification deficits identify Parkinson's disease patients with poor cognitive performance. Movement Disorders, 26, 2045-2050.
43. Delazer, M., Sinz, H., Zamarian, L., Stockner, H., Seppi, K., Wenning, G.,., Poewe, W., (2009). Decision making under risk and under ambiguity in Parkinson's disease. Neuropsychologia, 47, 1901-1908.
44. Dewey, R., Taneja, A., McClintock, S., Cullum, C., Dewey, R., Bernstein, I., &, Husain, M., (2012). Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression. Cognitive and Behavioral Neurology, 25, 115-120.
45. Dirnberger, G., Frith, C. D., &, Jahanshahi, M., (2005). Executive dysfunction in Parkinson's disease is associated with altered pallidal-frontal processing. Neuroimage, 25, 588-599.
46. Djamshidian, A., Cardoso, F., Grosset, D., Bowden-Jones, H., &, Lees, A., (2011). Pathological gambling in Parkinson's disease. Movement Disorders, 26, 1976-1984.
47. Domellof, M., Elgh, E., &, Forsgren, L., (2011). The relation between cognition and motor dysfunction in drug-naive newly diagnosed patients with Parkinson's disease. Movement Disorders, 26, 2183-2189.
48. Dubois, B., Slachevsky, A., Litvan, I., &, Pillon, B., (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55, 1621-1626.
49. Dujardin, K., Defebvre, L., Krystkowiak, P., Blond, S., &, Destée, A., (2001). Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. Journal of Neurology, 248, 603-611.
50. Dujardin, K., Degreef, J., Rogelet, P., Defebvre, L., &, Destée, A., (1999). Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease. Journal of Neurology, 246, 783-788.
51. Dujardin, K., Duhamel, A., Delliaux, M., Thomas-Antérion, C., Destée, A., &, Defebvre, L., (2010). Cognitive complaints in Parkinson's disease: Its relationship with objective cognitive decline. Journal of Neurology, 257, 79-84.
52. Dujardin, K., Sockeel, P., Delliaux, M., Destée, A., &, Defebvre, L., (2009). Apathy may herald cognitive decline and dementia in Parkinson's disease. Movement Disorders, 24, 2391-2397.
53. Elgh, E., Domellof, M., Linder, J., Edstrom, M., Stenlund, H., &, Forsgren, L., (2009). Cognitive function in early Parkinson's disease: A population-based study. European Journal of Neurology, 16, 1278-1284.
54. Emre, M., Aarsland, D., Brown, R., Burn, D., Duyckaerts, C., Mizuno, Y.,., Dubois, B., (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders, 22, 1689-1707.
55. Euteneuer, F., Schaefer, F., Stuermer, R., Boucsein, W., Timmermann, L., Barbe, M.,., Kalbe, E., (2009). Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease. Neuropsychologia, 47, 2882-2890.
56. Evans, A., Strafella, A., Weintraub, D., &, Stacy, M., (2009). Impulsive and compulsive behaviors in Parkinson's disease. Movement Disorders, 24, 1561-1570.
57. Favre, E., Ballanger, B., Thobois, S., Broussolle, E., &, Boulinguez, P., (2013). Deep brain stimulation of the subthalamic nucleus, but not dopaminergic medication, improves proactive inhibitory control of movement initiation in Parkinson's disease. Neurotherapeutics, 10, 154-167.
58. Fimm, B., Bartl, G., Zimmermann, P., &, Wallesch, C., (1994). Different mechanisms underly shifting set on external and internal cues in Parkinson's disease. Brain and Cognition, 25, 297-304.
59. Foltynie, T., Brayne, C., Robbins, T., &, Barker, R., (2004). The cognitive ability of an incident cohort of Parkinson's patients in the UK. Brain, 127, 550-560.
60. Gauggel, S., Rieger, M., &, Feghoff, T., (2004). Inhibition of ongoing responses in patients with Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 75, 539-544.
61. Georgiou, N., Bradshaw, J., Iansek, R., Phillips, J., Mattingley, J., &, Bradshaw, J., (1994). Reduction in external cues and movement sequencing in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 57, 368-370.
62. Georgiou, N., Iansek, R., Bradshaw, J., Phillips, J., Mattingley, J., &, Bradshaw, J., (1993). An evaluation of the role of internal cues in the pathogenesis of parkinsonian hypokinesia. Brain, 116, 1575-1587.
63. Godefroy, O., Azouvi, P., Robert, P., Roussel, M., LeGall, D., &, Meulemans, T., (2010). Dysexecutive syndrome: Diagnostic criteria and validation study. Annals of Neurology, 68, 855-864.
64. Gotham, A. M., Brown, R. G., &, Marsden, C. D., (1988). 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain, 111, 299-321.
65. Grace, J., Amick, M., D'Abreu, A., Festa, E., Heindel, W., &, Ott, B., (2005). Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease. Journal of the International Neuropsychological Society, 11, 766-775.
66. Graham, J., &, Sagar, H., (1999). A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: Identification of three distinct subtypes. Movement Disorders, 14, 10-20.
67. Hely, M., Reid, W., Adena, M., Halliday, G., &, Morris, J., (2008). The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years. Movement Disorders, 23, 837e44.
68. Herrera, E., Cuetos, F., &, Ribacoba, R., (2012). Verbal fluency in Parkinson's disease patients on/off dopamine medication. Neuropsychologia, 50, 3636-3640.
69. Hindle, J., Petrelli, A., Clare, L., &, Kalbe, E., (2013). Nonpharmacological enhancementof cognitive function in Parkinson's disease: A systematic review. Movement Disorders. Advance online publication.
70. Hsieh, S., Lee, C. Y., &, Tai, C., (1995). Set-shifting aptitude in Parkinson's disease: External versus internal cues. Psychological Reports, 77, 339-349.
71. Imamura, K., Wada-Isoe, K., Kitayama, M., &, Nakashima, K., (2008). Executive dysfunction in non-demented Parkinson's disease patients with hallucinations. Acta Neurologica Scandinavia, 117, 255-259.
72. Jacobs, D., Shuren, J., Bowers, D., &, Heilman, K., (1995). Emotional facial imagery, perception, and expression in Parkinson's disease. Neurology, 45, 1696-1702.
73. Jahanshahi, M., (2003). Reaction time as an index of motor preparation/programming and speed of response initiation. In, M. Hallett, (Ed.), Handbook of clinical neurophysiology: movement disorders (Vol. 1, pp. 203-229). Amsterdam: Elsevier.
74. Jahanshahi, M., Jenkins, I., Brown, R. G., Marsden, C. D., Passingham, R., &, Brooks, D., (1995). Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain, 118, 913-933.
75. Jahanshahi, M., &, Marsden, C. D., (1998). Living and coping with Parkinson's disease: A self-help guide for patients and their carers Human Horizon Series, London: Souvenir Press.
76. Jahanshahi, M., Wilkinson, L., Gahir, H., Dharminda, A., &, Lagnado, D., (2010). Medication impairs probabilistic classification learning in Parkinson's disease. Neuropsychologia, 48, 1096-1103.
77. Janvin, C. C., Aarsland, D., &, Larsen, J., (2005). Cognitive predictors of dementia in Parkinson's disease: A community-based, 4-year longitudinal study. Journal of Geriatric Psychiatry and Neurology, 18, 149-154.
78. Kalaitzakis, M. E., &, Pearce, R., (2009). The morbid anatomy of dementia in Parkinson's disease. Acta Neuropathologica, 118, 587-598.
79. Kandiah, N., Narasimhalu, K., Lau, P., Seah, S., Au, W., &, Tan, L., (2009). Cognitive decline in early Parkinson's disease. Movement Disorders, 24, 605-616.
80. Katzen, H., Levin, B., &, Weiner, W., (2006). Side and type of motor symptom influence cognition in Parkinson's disease. Movement Disorders, 21, 1947-1953.
81. Kish, S., Shannak, K., &, Hornykiewicz, O., (1988). Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. New England Journal of Medicine, 318, 876-880.
82. Kliegel, M., Altgassen, M., Hering, A., &, Rose, N., (2011). A process-model based approach to prospective memory impairment in Parkinson's disease. Neuropsychologia, 49, 2166-2177.
83. Kobayakawa, M., Koyama, S., Mimura, M., &, Kawamura, M., (2008). Decision making in Parkinson's disease. Movement Disorders, 23, 547-552.
84. Koerts, J., Beilen, M., Tucha, O., Leenders, K., &, Brouwer, W., (2011). Executive functioning in daily life in Parkinson's disease: Initiative, planning and multi-task performance. Public Library of Science One, 6, e29254.
85. Koerts, J., Tucha, L., Leenders, K., Beilen, M., Brouwer, W., &, Tucha, O., (2011). Subjective and objective assessment of executive functions in Parkinson's disease. Journal of the Neurological Sciences, 310, 172-175.
86. Kudlicka, A., Clare, L., &, Hindle, J., (2011). Executive functions in Parkinson's disease: Systematic review and meta-analysis. Movement Disorders, 26, 2305-2315.
87. Kummer, A., Harsányi, E., Dias, F., Cardoso, F., Caramelli, P., &, Teixeira, A., (2009). Depression impairs executive functioning in Parkinson disease patients with low educational level. Cognitive and Behavioral Neurology, 22, 167-172.
88. Lafleche, G., &, Albert, M., (1995). Executive function deficits in mild Alzheimer's disease. Neuropsychology, 9, 313-320.
89. Lange, K. W., Robbins, T., Marsden, C., James, M., Owen, A., &, Paul, G., (1992). L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology (Berl), 107, 394-404.
90. Lees, A., &, Smith, E., (1983). Cognitive deficits in the early stages of Parkinson's disease. Brain, 106, 257-270.
91. Levy, G., Jacobs, D., Tang, M., Côté, L., Louis, E., Alfaro, B.,., Marder, K., (2002). Memory and executive function impairment predict dementia in Parkinson's disease. Movement Disorders, 17, 1221-1226.
92. Levy, G., Tang, M. X., Louis, E., Côté, L. J., Alfaro, B., Mejia, H.,., Marder, K., (2002). The association of incident dementia with mortality in PD. Neurology, 59, 1708-1713.
93. Lewis, S. J., Dove, A., Robbins, T., Barker, R., &, Owen, A. M., (2003). Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. Journal of Neuroscience, 23, 6351-6356.
94. Lewis, S. J., Slabosz, A., Robbins, T. W., Barker, R. A., &, Owen, A. M., (2005). Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease. Neuropsychologia, 43, 823-832.
95. Lezak, M.D., (1995). Neuropsychological assessment (3rd ed.). New York, NY: Oxford University Press.
96. Litvan, I., Aarsland, D., Adler, C., Goldman, J. G., Kulisevsky, J., Mollenhauer, B.,., Weintraub, D., (2011). MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI. Movement Disorders, 26, 1814-1824.
97. Litvan, I., Goldman, J., Tröster, A., Schmand, B., Weintraub, D., Petersen, R.,., Emre, M., (2012). Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27, 349-356.
98. Lord, S., Rochester, L., Hetherington, V., Allcock, L., &, Burn, D., (2010). Executive dysfunction and attention contribute to gait interference in 'off' state Parkinson's disease. Gait and Posture, 31, 169-174.
99. MacDonald, P., &, Monchi, O., (2011). Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: Implications for cognitive function. Parkinson's Disease, Article ID 572743.
100. Mahieux, F., Fénelon, G., Flahault, A., Manifacier, M., Michelet, D., &, Boller, F., (1998). Neuropsychological prediction of dementia in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 64, 178-183.
101. Manning, K., Clarke, C., Lorry, A., Weintraub, D., Wilkinson, J., Duda, J., &, Moberg, P., (2012). Medication management and neuropsychological performance in Parkinson's disease. The Clinical Neuropsychologist, 26, 45-58.
102. Marinus, J., Visser, M., Verwey, N., Verhey, F., Middelkoop, H., Stiggelbout, A., &, van Hilten, J., (2003). Assessment of cognition in Parkinson's disease. Neurology, 61, 1222-1228.
103. Miah, I., Dubbelink, K., Stoffers, D., Deijen, J., &, Berendse, H., (2012). Early-stage cognitive impairment in Parkinson's disease and the influence of dopamine replacement therapy. European Journal of Neurology, 19, 510-516.
104. Miller, E. K., &, Cohen, J. D., (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24, 167-202.
105. Miller, I., &, Cronin-Golomb, A., (2010). Gender differences in Parkinson's disease: Clinical characteristics and cognition. Movement Disorders, 25, 2695-2703.
106. Mimura, M., Oeda, R., &, Kawamura, M., (2006). Impaired decision-making in Parkinson's disease. Parkinsonism and Related Disorders, 12, 169-175.
107. Mohlman, J., Chazin, D., &, Georgescu, B., (2011). Feasibility and acceptance of a nonpharmacological cognitive remediation intervention for patients with Parkinson disease. Journal of Geriatric Psychiatry and Neurology, 24, 91-97.
108. Molina, J., Sainz-Artiga, M., Fraile, A., Jimenez-Jimenez, F., Villanueva, C., Orti-Pareja, M., &, Bermejo, F., (2000). Pathological gambling in Parkinson's disease. Movement Disorders, 15, 869-872.
109. Muslimovic, D., Post, B., Speelman, J., Haan, R., &, Schmand, B., (2009). Cognitive decline in Parkinson's disease: A prospective longitudinal study. Journal of the International Neuropsychological Society, 15, 426-437.
110. Muslimovic, D., Post, B., Speelman, J., &, Schmand, B., (2005). Cognitive profile of patients with newly diagnosed Parkinson's disease. Neurology, 65, 1239-1245.
111. Muslimovic, D., Schmand, B., Speelman, J., &, de Haan, R., (2007). Course of cognitive decline in Parkinson's disease: A meta-analysis. Journal of the International Neuropsychological Society, 13, 920-932.
112. Nelson, H., (1976). A modified card sorting test sensitive to frontal lobe defects. Cortex, 12, 313-324.
113. NIH (2013). Parkinson's disease research agenda implementation review meeting. Retrived from http://www.ninds.nih.gov/news-and-events/proceedings/pd- research-agenda-2002.htm?css=print
114. Nocera, J., Price, C., Fernandez, H., Amano, S., Vallabhajosula, S., Okun, M.,., Hass, C., (2010). Tests of dorsolateral frontal function correlate with objective stability in early to moderate stage Parkinson's disease. Parkinsonism and Related Disorders, 16, 590-594.
115. Norman, D., &, Shallice, T., (1986). Attention to action: Willed and automatic control of behaviour. In, R. Davidson, G. Schwartz, &, D. Shapiro, (Eds.), Consciousness and self-regulation, Vol. 4 (pp. 1-18). New York, NY: Plenum.
116. Obeso, I., Casabona, E., Bringas, M. L., Álvarez, L., &, Jahanshahi, M., (2012). Semantic and phonemic verbal fluency in Parkinson's disease: Influence of clinical and demographic variables. Behavioral Neurology, 25, 111-118.
117. Obeso, I., Wilkinson, L., Casabona, E., Bringas, M., Álvarez, M., Álvarez, L.,., Jahanshahi, M., (2011). Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease. Experimental Brain Research, 212, 371-384.
118. Obeso, I., Wilkinson, L., &, Jahanshahi, M., (2011). Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease. Experimental Brain Research, 213, 435-445.
119. O'Shea, S., Morris, M., &, Iansek, R., (2002). Dual task interference during gait in people with Parkinson disease: Effect of motor versus cognitive secondary tasks. Physical Therapy, 82, 888-897.
120. Owen, A. M., Beksinska, M., James, M., Leigh, P., Summers, B., Marsden, C. D.,., Robbins, T., (1993). Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia, 31, 627-644.
121. Owen, A., Doyon, J., Dagher, A., Sadikot, A., &, Evans, A., (1998). Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Brain, 121, 949-965.
122. Owen, A. M., Iddon, J., Hodges, J., Summers, B., &, Robbins, T., (1997). Spatial and non-spatial working memory at different stages of Parkinson's disease. Neuropsychologia, 35, 519-532.
123. Owen, A. M., James, M., Leigh, P., Summers, B., Marsden, C., Quinn, N.,., Robbins, T., (1992). Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain, 115, 1727-1751.
124. Ozer, F., Meral, H., Hanoglu, L., Ozturk, O., Aydemir, T., Cetin, S.,., Tiras, R., (2007). Cognitive impairment patterns in Parkinson's disease with visual hallucinations. Journal of Clinical Neuroscience, 14, 742-746.
125. Pagonabarraga, J., Garcia-Sanchez, C., Llebaria, G., Pascual-Sedano, B., Gironell, A., &, Kulisevsky, J., (2007). Controlled study of decision-making and cognitive impairment in Parkinson's disease. Movement Disorders, 22, 1430-1435.
126. Parrao, T., Chana, P., Venegas, P., Behrens, M., &, Aylwin, M., (2012). Olfactory deficits and cognitive dysfunction in Parkinson's disease. Neurodegenerative Diseases, 10, 179-182.
127. Pascual-Sedano, B., Kulisevsky, J., Barbanoj, M., Garcia-Sanchez, C., Campolongo, A., Gironell, A.,., Gich, I., (2008). Levodopa and executive performance in Parkinson's disease. Journal of the International Neuropsychological Society, 14, 832-841.
128. Perretta, J., Pari, G., &, Beninger, R., (2005). Effects of Parkinson disease on two putative nondeclarative learning tasks: Probabilistic classification and gambling. Cognitive and Behavioural Neurology, 18, 185-192.
129. Plotnik, M., Giladi, N., Dagan, Y., &, Hausdorff, J., (2011). Postural instability and fall risk in Parkinson's disease: Impaired dual tasking, pacing, and bilateral coordination of gait during the 'on' medication state. Experimental Brain Research, 210, 529-538.
130. Pluck, G., &, Brown, R. G., (2002). Apathy in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 73, 636-642.
131. Poletti, M., &, Bonuccelli, U., (2012). Impulse control disorders in Parkinson' disease: The role of personality and cognitive status. Journal of Neurology, 259, 2269-2277.
132. Poletti, M., Cavedini, P., &, Bonuccelli, U., (2011). Iowa gambling task in Parkinson's disease. Journal of Clinical and Experimental Neuropsychology, 33, 395-409.
133. Poletti, M., Frosini, D., Lucetti, C., Del Dotto, P., Ceravolo, R., &, Bonuccelli, U., (2010). Decision making in de novo Parkinson's disease. Movement Disorders, 25, 1432-1436.
134. Poletti, M., Frosini, D., Pagni, C., Lucetti, C., Del Dotto, P., Tognoni, G.,., Bonuccelli, U., (2011). The association between motor subtypes and alexithymia in de novo Parkinson's disease. Journal of Neurology, 258, 1042-1045.
135. Poliakoff, E., &, Smith-Spark, J. H., (2008). Everyday cognitive failures and memory problems in Parkinson's patients without dementia. Brain and Cognition, 67, 340-350.
136. Ponsen, M., Stoffers, D., Twisk, J., Wolters, E., &, Berendse, H., (2009). Hyposmia and executive dysfunction as predictors of future Parkinson's disease. Movement Disorders, 24, 1060-1065.
137. Post, B., Speelman, J. D., &, de Haan, R., (2008). Clinical heterogeneity in newly diagnosed Parkinson's disease. Journal of Neurology, 255, 716-722.
138. Praamstra, P., &, Plat, F., (2001). Failed suppression of direct visuomotor activation in Parkinson's disease. Journal of Cognitive Neuroscience, 13, 31-43.
139. Rahman, S., Griffin, H., Quinn, N. P., &, Jahanshahi, M., (2008). Quality of life in Parkinson's disease: The relative importance of the symptoms. Movement Disorders, 23, 1428-1434.
140. Redgrave, P., Rodriguez, M., Smith, Y., Rodriguez-Oroz, M., Lehericy, S., Bergman, H.,., Obeso, J., (2010). Goal-directed and habitual control in the basal ganglia: Implications for Parkinson's disease. Nature Reviews Neuroscience, 11, 760-772.
141. Reijnders, J., Ehrt, U., Lousberg, R., Aarsland, D., &, Leentjens, A., (2009). The association between motor subtypes and psychopathology in Parkinson's disease. Parkinsonism and Related Disorders, 15, 379-382.
142. Reitan, R., (1958). Validity of the trail making test as an indicator of organic brain damage. Perceptual and Motor Skills, 8, 271-276.
143. Reuter, I., Mehnert, S., Sammer, G., Ochsner, M., &, Engelhardt, M., (2012). Efficacy of a multimodal cognitive rehabilitation including psychomotor and endurance training in Parkinson's disease. Journal of Aging Research, Article ID 235765. doi:1155/2012/235765
144. Ridgel, A., Kim, C., Fickes, E., Muller, M., &, Alberts, J., (2011). Changes in executive function after acute bouts of passive cycling in Parkinson's disease. Journal of Aging and Physical Activity, 19, 87-98.
145. de Rijk, M. C., Launer, L., Berger, K., Breteler, M., Dartigues, J., Baldereschi, M.,., Hofman, A., (2000). Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurology, 54, 21-23.
146. Robbins, T., (2007). Shifting and stopping: Fronto-striatal substrates, neurochemical modulation and clinical implications. Philosophical Transactions of the Royal Society of London, Series B, Biological Sciences, 362, 917-932.
147. Robertson, C., Hazlewood, R., &, Rawson, M., (1996). The effects of Parkinson's disease on the capacity to generate information randomly. Neuropsychologia, 14, 1069-1078.
148. Rochester, L., Nieuwboer, A., Baker, K., Hetherington, V., Willems, A., Kwakkel, G.,., Jones, D., (2008). Walking speed during single and dual tasks in Parkinson's disease: Which characteristics are important? Movement Disorders, 23, 2312-2318.
149. Rowe, J., Hughes, L., Ghosh, B., Eckstein, D., Williams-Gray, C., Fallon, S.,., Owen, A. M., (2008). Parkinson's disease and dopaminergic therapy-Differential effects on movement, reward and cognition. Brain, 131, 2094-2105.
150. Saint-Cyr, J., Taylor, A., &, Lang, A., (1988). Procedural learning and neostriatal dysfunction in man. Brain, 111, 941-959.
151. Saltzman, J., Strauss, E., Hunter, M., &, Archibald, S., (2000). Theory of mind and executive functions in normal human aging and Parkinson's disease. Journal of the International Neuropsychological Society, 6, 781-788.
152. Santangelo, G., Trojano, L., Vitale, C., Ianniciello, M., Amboni, M., &, Grossi, D., (2007). A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. Movement Disorders, 22, 2418-2425.
153. Santangelo, G., Vitale, C., Trojano, L., Errico, D., Amboni, M., Barbarulo, A.,., Barone, P., (2012). Neuropsychological correlates of theory of mind in patients with early Parkinson's disease. Movement Disorders, 27, 98-105.
154. Schmitt, F., Farlow, M., Meng, X., Tekin, S., &, Olin, J., (2010). Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia. CNS Neuroscience Therapies, 16, 330-336.
155. Schrag, A., Jahanshahi, M., &, Quinn, N., (2000). What contributes to quality of life in patients with Parkinson's disease? Journal of Neurology, Neurosurgery and Psychiatry, 69, 308-312.
156. Schrag, A., &, Schott, J., (2006). Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurology, 5, 355-363.
157. Seguin, J., Arseneault, L., &, Tremblay, R., (2007). The contribution of "cool" and "hot" components of decision-making in adolescence: Implications for psychopathology. Cognitive Development, 22, 530-543.
158. Shallice, T., &, Burgess, P. W., (1991). Deficits in strategy application following frontal lobe damage in man. Brain, 114, 727-741.
159. Shin, S., Lee, J., Hong, J., Sunwoo, M., Sohn, Y., &, Lee, P., (2012). Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry, 83, 1155-1161.
160. Spatt, J., &, Goldenberg, G., (1993). Components of random generation by normal subjects and patients with dysexecutive function. Brain and Cognition, 23, 231-242.
161. Starkstein, S., Petracca, G., Chemerinski, E., Tesõn, A., Sabe, L., Merello, M., &, Leiguarda, R., (1998). Depression in classic versus akinetic-rigid Parkinson disease. Movement Disorders, 39, 1441-1445.
162. Starkstein, S. E., Preziosi, T., Berthier, M., Bolduc, P., Mayberg, H., &, Robinson, R., (1989). Depression and cognitive impairment in Parkinson's disease. Brain, 112, 1141-1153.
163. Stavitsky, K., Neargarder, S., Bogdanova, Y., McNamara, P., &, Cronin-Golomb, A., (2011). The impact of sleep quality on cognitive functioning in Parkinson's disease. Journal of the International Neuropsychological Society, 18, 1-10.
164. Stefanova, E., Potrebic, A., Ziropadja, L., Maric, J., Ribaric, I., &, Kostic, V., (2006). Depression predicts the pattern of cognitive impairment in early Parkinson's disease. Journal of the Neurological Sciences, 248, 131-137.
165. Stolwyk, R., Charlton, J., Triggs, T., Iansek, R., &, Bradshaw, J., (2006). Neuropsychological function and driving ability in people with Parkinson's disease. Journal of Clinical and Experimantal Neuropsychology, 28, 898-913.
166. Stroop, J. R., (1935). Studies of interference in serial verbal reactions. Journal of Experimental Psychology, 18, 643-662.
167. Swainson, R., Rogers, R., Sahakian, B., Summers, B., Polkey, C., &, Robbins, T., (2000). Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: Possible adverse
168. Taylor, A. E., &, Saint-Cyr, J. A., (1995). The neuropsychology of Parkinson's disease. Brain and Cognition, 28, 281-296.
169. Taylor, A. E., Saint-Cyr, J. A., &, Lang, A., (1986). Frontal lobe dysfunction in Parkinson's disease: The cortical focus of neostriatal outflow. Brain, 109, 279-292.
170. Thaler, A., Posen, J., Giladi, N., Manor, Y., Mayanz, C., Mirelman, A., &, Gurevich, T., (2012). Appreciation of humor is decreased among patients with Parkinson's disease. Parkinsonism and Related Disorders, 18, 144-148.
171. Thiel, A., Hilker, R., Kessler, J., Habedank, B., Herholz, K., &, Heiss, W., (2003). Activation of basal ganglia loops in idiopathic Parkinson's disease. Journal of Neural Transmission, 110, 1289-1301.
172. Tomer, R., Levin, B. E., &, Weiner, W. J., (1993). Side of onset of motor symptoms influences cognition in Parkinson's disease. Annals of Neurology, 34, 579-584.
173. Tremblay, C., Achim, A., Macoir, J., &, Monetta, L., (2013). The heterogeneity of cognitive symptoms in Parkinson's disease: A meta-analysis. Journal of Neurology, Neurosurgery and Psychiatry. Advance online publication.
174. Uc, E., Rizzo, M., Anderson, S., Sparks, J., Rodnitzky, R., &, Dawson, J., (2006). Impaired visual search in drivers with Parkinson's disease. Annals of Neurology, 60, 407-413.
175. Uekermann, J., Daum, I., Bielawski, M., Muhlack, S., Peters, S., Przuntek, H., &, Mueller, T., (2004). Differential executive control impairments in early Parkinson's disease. Journal of Neural Transmission Supplement, 2004, 39-51.
176. Varanese, S., Perfetti, B., Ghilardi, M., &, di Rocco, A., (2011). Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson's disease. Public Library of Science One, 6, e17846.
177. Vercruysse, S., Devos, H., Munks, L., Spildooren, J., Vandenbossche, J., Vandenberghe, W.,., Heremans, E., (2012). Explaining freezing of gait in Parkinson's disease: Motor and cognitive determinants. Movement Disorders, 27, 1644-1651.
178. Verreyt, N., Nys, G., Santens, P., &, Vingerhoets, G., (2011). Cognitive differences between patients with left-sided and right-sided Parkinson's disease. Neuropsychological Review, 21, 405-424.
179. de Vito, S., Gamboz, N., Brandimonte, M., Barone, P., Amboni, M., &, Della Sala, S., (2012). Future thinking in Parkinson's disease: An executive function? Neuropsychologia, 50, 1494-1501.
180. Voon, V., &, Fox, S., (2007). Medication-related impulse control and repetitive behaviors in Parkinson disease. Archives of Neurology, 64, 1089-1096.
181. Wechsler, D., &, Stone, C., (1987). Wechsler memory scale-Revised (WMSR). San Antonio, TX: The Psychological Corporation.
182. Weingartner, H., Burns, S., Diebel, R., &, Le Witt, P., (1984). Cognitive impairments in Parkinson's disease: Distinguishing between effort-demanding and automatic cognitive processes. Psychiatry Research, 11, 223-235.
183. Weintraub, D., Koester, J., Potenza, M., Siderowf, A., Stacy, M., Voon, V.,., Lang, A. E., (2010). Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology, 67, 589-595.
184. Weintraub, D., Moberg, P., Culbertson, W., Duda, J., Katz, I., &, Stern, M., (2005). Dimensions of executive function in Parkinson's disease. Dementia and Geriatric Cognitive Disorders, 20, 140-144.
185. Williams, L., Seignourel, P., Crucian, G., Okun, M., Rodriguez, R., Skidmore, F.,., Fernandez, H., (2007). Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease. Movement Disorders, 22, 141-145.
186. Williams-Gray, C., Foltynie, T., Brayne, C., Robbins, T., &, Barker, R., (2007). Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain, 130, 1787-1798.
187. Williams-Gray, C., Hampshire, A., Barker, R., &, Owen, A., (2008). Attentional control in Parkinson's disease is dependent on COMT val[158]met genotype. Brain, 131, 397-408.
188. Wilson, B., Alderman, N., Burgess, P., Emslie, H., &, Evans, J., (1996). Behavioural assessment of the dysexecutive syndrome. Edmunds, UK: Thames Valley Test Company.
189. Wylie, S., Ridderinkhof, K., Bashore, T., &, van den Wildenberg, W., (2010). The effect of Parkinson's disease on the dynamics of on-line and proactive cognitive control during action selection. Journal of Cognitive Neuroscience, 22, 2058-2073.
190. Wylie, S., van den Wildenberg, W., Ridderinkhof, K., Bashore, T., Powell, V., Manning, C., &, Wooten, G., (2009a). The effect of Parkinson's disease on interference control during action selection. Neuropsychologia, 47, 145-157.
191. Wylie, S., van den Wildenberg, W., Ridderinkhof, K., Bashore, T., Powell, V., Manning, C., &, Wooten, G., (2009b). The effect of speed-accuracy strategy on response interference control in Parkinson's disease. Neuropsychologia, 47, 1844-1853.
192. Yogev, G., Giladi, N., Peretz, C., Springer, S., Simon, E., &, Hausdorff, J., (2005). Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding? European Journal of Neuroscience, 22, 1248-1256.
193. Zgaljardic, D., Borod, J., Foldi, N., Mattis, P., Gordon, M., Feigin, A., &, Eidelberg, D., (2006). An examination of executive dysfunction associated with frontostriatal circuitry in Parkinson's disease. Journal of Clinical and Experimental Neuropsychology, 28, 1127-1144.
194. Zgaljardic, D., Borod, J., Foldi, N., Rocco, M., Mattis, P., Gordon, M.,., Eidelberg, D., (2007). Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cognitive and Behavioral Neurology, 20, 184-192.